Schmitz S - Search Results

1

Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease.

Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Minthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Teipel SJ, Weiner M, Hampel H; Alzheimer's Disease Neuroimaging Initiative. Ewers M, et al. Among authors: schmitz s. Neurobiol Aging. 2012 Aug;33(8):1599-608. doi: 10.1016/j.neurobiolaging.2011.05.005. Epub 2011 Jun 17. Neurobiol Aging. 2012. PMID: 21684041 Free PMC article.

2

The use of continuous data versus binary data in MTC models: a case study in rheumatoid arthritis.

Schmitz S, Adams R, Walsh C. Schmitz S, et al. BMC Med Res Methodol. 2012 Nov 6;12:167. doi: 10.1186/1471-2288-12-167. BMC Med Res Methodol. 2012. PMID: 23130635 Free PMC article.

3

Incorporating data from various trial designs into a mixed treatment comparison model.

Schmitz S, Adams R, Walsh C. Schmitz S, et al. Stat Med. 2013 Jul 30;32(17):2935-49. doi: 10.1002/sim.5764. Epub 2013 Feb 25. Stat Med. 2013. PMID: 23440610

4

A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach.

Schmitz S, Adams R, Walsh CD, Barry M, FitzGerald O. Schmitz S, et al. Ann Rheum Dis. 2012 Feb;71(2):225-30. doi: 10.1136/annrheumdis-2011-200228. Epub 2011 Sep 29. Ann Rheum Dis. 2012. PMID: 21960560

5

Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer.

McCullagh L, Schmitz S, Barry M, Walsh C. McCullagh L, et al. Among authors: schmitz s. Pharmacoeconomics. 2017 Nov;35(11):1177-1185. doi: 10.1007/s40273-017-0552-y. Pharmacoeconomics. 2017. PMID: 28770453

6

Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis.

Fogarty E, Schmitz S, Tubridy N, Walsh C, Barry M. Fogarty E, et al. Among authors: schmitz s. Mult Scler Relat Disord. 2016 Sep;9:23-30. doi: 10.1016/j.msard.2016.06.001. Epub 2016 Jun 8. Mult Scler Relat Disord. 2016. PMID: 27645339 Review.

7

Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.

Schmitz S, McCullagh L, Adams R, Barry M, Walsh C. Schmitz S, et al. Pharmacoeconomics. 2016 Sep;34(9):925-37. doi: 10.1007/s40273-016-0406-z. Pharmacoeconomics. 2016. PMID: 27034245

8

The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.

Kieran J, Schmitz S, O'Leary A, Walsh C, Bergin C, Norris S, Barry M. Kieran J, et al. Among authors: schmitz s. Clin Infect Dis. 2013 Jan;56(2):228-35. doi: 10.1093/cid/cis880. Epub 2012 Oct 16. Clin Infect Dis. 2013. PMID: 23074309 Review.

9

Reply to Calcagno et al.

Kieran JA, Schmitz S, O'Leary A, Walsh C, Bergin C, Norris S, Barry MG. Kieran JA, et al. Among authors: schmitz s. Clin Infect Dis. 2013 Jun;56(11):1678-9. doi: 10.1093/cid/cit092. Epub 2013 Feb 15. Clin Infect Dis. 2013. PMID: 23418277 No abstract available.

10

Harms of off-label erythropoiesis-stimulating agents for critically ill people.

Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. Mesgarpour B, et al. Among authors: schmitz s. Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010969. doi: 10.1002/14651858.CD010969.pub2. Cochrane Database Syst Rev. 2017. PMID: 28841235 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

873 results

Search Page